Penelope Bouziotis

Athens, ESYE31 15341, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Lutetium-177 Radiolabeled Gold Nanoparticles for Prostate Cancer Theranostics.

Lutetium-177 Radiolabeled Gold Nanoparticles for Prostate Cancer Theranostics.

Journal: Nanomaterials (Basel, Switzerland)

Published: February 27, 2026

Radiolabeled Angiopep-2 Peptide Vector as a Preclinical Platform for Blood-Brain Barrier Targeting: Synthesis, Radiolabeling, and Preliminary In Vivo Biodistribution in Mice.

Radiolabeled Angiopep-2 Peptide Vector as a Preclinical Platform for Blood-Brain Barrier Targeting: Synthesis, Radiolabeling, and Preliminary In Vivo Biodistribution in Mice.

Journal: Journal of peptide science : an official publication of the European Peptide Society

Published: January 14, 2026

Development of AGT-7: An Innovative 99mTc-Labeled Theranostic Platform for Glioblastoma Imaging and Therapy.

Development of AGT-7: An Innovative 99mTc-Labeled Theranostic Platform for Glioblastoma Imaging and Therapy.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 04, 2025

IAEA activities to support the member states in the production of targeted alpha therapy radiopharmaceuticals.

IAEA activities to support the member states in the production of targeted alpha therapy radiopharmaceuticals.

Journal: Nuclear medicine and biology

Published: November 14, 2024

161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer.

161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer.

Journal: Materials (Basel, Switzerland)

Published: November 01, 2024

Design Principles and Applications of Fluorescent Kinase Inhibitors for Simultaneous Cancer Bioimaging and Therapy.

Design Principles and Applications of Fluorescent Kinase Inhibitors for Simultaneous Cancer Bioimaging and Therapy.

Journal: Cancers

Published: September 24, 2024

Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer.

Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer.

Journal: ACS medicinal chemistry letters

Published: August 11, 2024

177Lu-Labeled Iron Oxide Nanoparticles Functionalized with Doxorubicin and Bevacizumab as Nanobrachytherapy Agents against Breast Cancer.

177Lu-Labeled Iron Oxide Nanoparticles Functionalized with Doxorubicin and Bevacizumab as Nanobrachytherapy Agents against Breast Cancer.

Journal: Molecules (Basel, Switzerland)

Published: January 09, 2024

Gamma-Camera Direct Imaging of the Plasma and On/Intra Cellular Distribution of the 99mTc-DPD-Fe3O4 Dual-Modality Contrast Agent in Peripheral Human Blood.

Gamma-Camera Direct Imaging of the Plasma and On/Intra Cellular Distribution of the 99mTc-DPD-Fe3O4 Dual-Modality Contrast Agent in Peripheral Human Blood.

Journal: Materials (Basel, Switzerland)

Published: December 01, 2023

Nuclear Medicine and Cancer Theragnostics: Basic Concepts.

Nuclear Medicine and Cancer Theragnostics: Basic Concepts.

Journal: Diagnostics (Basel, Switzerland)

Published: September 09, 2023

Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold Nanoparticles.

Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold Nanoparticles.

Journal: Molecular pharmaceutics

Published: August 22, 2023

Metal-binding cyclodextrins: Synthesis and complexation with Zn2+ and Ga3+ cations towards antimicrobial applications.

Metal-binding cyclodextrins: Synthesis and complexation with Zn2+ and Ga3+ cations towards antimicrobial applications.

Journal: Carbohydrate polymers

Published: May 20, 2023

Showing 1-12 of 64

Last Updated: 09/26/2026